Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.55
+0.15 (0.41%)
Jun 27, 2025, 1:30 PM CST

Synmosa Biopharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
710.08684.68594.83799.09303.86638.11
Upgrade
Depreciation & Amortization
332.98335.41334.83315.64297.29296.7
Upgrade
Other Amortization
6.816.565.094.744.775.46
Upgrade
Loss (Gain) From Sale of Assets
0.490.44-0.12-281.43-11.86-0.68
Upgrade
Asset Writedown & Restructuring Costs
-0.2410.8615.228.2144.32
Upgrade
Loss (Gain) From Sale of Investments
86.0663.83-49.82-50.41-4.75-233.52
Upgrade
Loss (Gain) on Equity Investments
13.4313.7810.3316.5616.41.54
Upgrade
Stock-Based Compensation
19.1414.6417.2122.4710.644.3
Upgrade
Provision & Write-off of Bad Debts
-1.21-0.496.743.411.829.94
Upgrade
Other Operating Activities
-203.97-188.89-98.04-59.33-147.25-275.64
Upgrade
Change in Accounts Receivable
-104.44-130.66-27.87-244.16-77.74-13.62
Upgrade
Change in Inventory
-260.24-110.39-305.39-120.9416.87-172.66
Upgrade
Change in Accounts Payable
195.3347.31-8.09147.9565.26-114.81
Upgrade
Change in Unearned Revenue
9.65-5.391.2146.36-2.44-1.85
Upgrade
Change in Other Net Operating Assets
60.6849.5520.1515.08-26.2151.51
Upgrade
Operating Cash Flow
864.79780.62511.93630.25454.86254.4
Upgrade
Operating Cash Flow Growth
65.56%52.49%-18.77%38.56%78.80%-
Upgrade
Capital Expenditures
-239.76-214.52-207.04-129.3-93.06-154.41
Upgrade
Sale of Property, Plant & Equipment
3.083.131.62305.18240.579.65
Upgrade
Cash Acquisitions
---48.83-95.86-7.5282.91
Upgrade
Sale (Purchase) of Intangibles
-41.49-55.13-53.48-55.03-49.07-22.8
Upgrade
Investment in Securities
-22.88-105.94-402.88-96.92-2.1290.55
Upgrade
Other Investing Activities
38.9335.66-7.252.59-15.4828.59
Upgrade
Investing Cash Flow
-262.11-336.8-717.87-69.3373.3334.5
Upgrade
Short-Term Debt Issued
-13.62127.07-133-
Upgrade
Long-Term Debt Issued
-159.01493350-1,683
Upgrade
Total Debt Issued
126.17172.62620.073501331,683
Upgrade
Short-Term Debt Repaid
---50-179.76--756
Upgrade
Long-Term Debt Repaid
--72.09-1,532-344.65-381.84-892.37
Upgrade
Total Debt Repaid
-72.85-72.09-1,582-524.41-381.84-1,648
Upgrade
Net Debt Issued (Repaid)
53.32100.54-962.15-174.41-248.8435.05
Upgrade
Issuance of Common Stock
1,057-95040.230.61-
Upgrade
Repurchase of Common Stock
----108.97-51.64-
Upgrade
Common Dividends Paid
-228.74-228.74-194.43-148.64-79.98-45.7
Upgrade
Other Financing Activities
-60.15-59.35243.8343.8482.28-101.14
Upgrade
Financing Cash Flow
821.43-187.5537.24-347.95-297.57-111.78
Upgrade
Foreign Exchange Rate Adjustments
7.8411.27-0.396.52-0.81-3.88
Upgrade
Net Cash Flow
1,432267.55-169.09219.48229.82173.24
Upgrade
Free Cash Flow
625.03566.1304.89500.95361.81100
Upgrade
Free Cash Flow Growth
127.31%85.68%-39.14%38.46%261.83%-
Upgrade
Free Cash Flow Margin
10.94%10.20%5.93%11.42%11.18%3.29%
Upgrade
Free Cash Flow Per Share
1.471.340.751.280.920.26
Upgrade
Cash Interest Paid
60.8460.0266.9759.2951.8253.42
Upgrade
Cash Income Tax Paid
0.78-5.5269.7665.019.63
Upgrade
Levered Free Cash Flow
525.36426.14148.45362.14420.14-282.46
Upgrade
Unlevered Free Cash Flow
562.15462.45190.44399.33452.62-249.45
Upgrade
Change in Net Working Capital
-2.4387.61291.6847.14-165.34472.14
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.